Stocks and Investing Stocks and Investing
Fri, January 31, 2020

Kevin Huang Maintained (VRTX) at Strong Buy with Increased Target to $286 on, Jan 31st, 2020


Published on 2024-10-26 21:11:20 -
  Print publication without navigation


Kevin Huang of CFRA, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $237 to $286 on, Jan 31st, 2020.

Kevin has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Kevin's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Kevin


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $265 on, Wednesday, January 8th, 2020
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019